---
category: news
title: "Lantern Pharma Announces Significant Positive Preclinical Data in Pancreatic Cancer With Drug Candidate LP-184"
excerpt: "PRNewswire/ -- Lantern Pharma (NASDAQ:LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence"
publishedDateTime: 2021-07-20T11:00:00Z
originalUrl: "https://www.benzinga.com/pressreleases/21/07/n22056896/lantern-pharma-announces-significant-positive-preclinical-data-in-pancreatic-cancer-with-drug-cand"
webUrl: "https://www.benzinga.com/pressreleases/21/07/n22056896/lantern-pharma-announces-significant-positive-preclinical-data-in-pancreatic-cancer-with-drug-cand"
ampWebUrl: "https://www.benzinga.com/amp/content/22056896"
cdnAmpWebUrl: "https://www-benzinga-com.cdn.ampproject.org/c/s/www.benzinga.com/amp/content/22056896"
type: article
quality: 24
heat: 24
published: false

provider:
  name: Benzinga.com
  domain: benzinga.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://s3.amazonaws.com/wp-uploads.benzinga-premium-newsletters.prod/uploads/2021/07/15155831/Options-Trades-Feb-3-2021-5.png"
    width: 1200
    height: 600
    isCached: true

secured: "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;GzKZjtrqNlaRUfbuOiDCWg=="
---

